Top Medical News
Diabetes, fertility treatment, family history up autism risk in infants
10 hours ago
A recent Egypt study has identified several maternal and neonatal factors contributing to the risk of autism spectrum disorders (ASD) in infants, including the use of assisted fertility treatments, family medical history, and threatened abortion.
Adult ADHD: Study debates on its possibilities and symptoms
The use of electroencephalogram-based neurofeedback (EEG-NF) can help combat inattention among adolescents and young adults, though its efficacy for controlling hyperactivity or impulsivity remains unestablished, a recent meta-analysis has found.
Paracetamol on par with ibuprofen, indomethacin in neonatal patent ductus arteriosus
2 days ago
Paracetamol is as safe and effective as ibuprofen or indomethacin in the treatment of patent ductus arteriosus (PDA) in preterm neonates, suggests a recent study. In addition, use of paracetamol results in fewer adverse effects.
Oral dexamethasone trumps prednisolone for acute asthma attacks in kids
Audrey Abella, 2 days ago
Oral dexamethasone proved more effective than oral prednisolone for the management of acute exacerbation of mild-to-moderate asthma in children, a study suggests.
Baricitinib delays, lowers frequency of flares in JIA
Roshini Claire Anthony, 3 days ago

In patients with juvenile idiopathic arthritis (JIA) with insufficient response to conventional synthetic (cs) or biologic (b) disease-modifying antirheumatic drugs (DMARDs), the JAK*1/2 selective inhibitor baricitinib reduced the frequency and delayed time to disease flares, according to a phase III trial presented at EULAR 2022.

NAFLD linked to heightened type 2 diabetes risk
4 days ago
Children with nonalcoholic fatty liver disease (NAFLD) are at an increased risk of type 2 diabetes, a study reports. Other risk factors for T2D include severity of liver histology, body mass index, and female sex.
Rapid childhood growth rate tied to elevated risk of islet autoimmunity, T1D development
Stephen Padilla, 5 days ago
Children who grow in height fast appears to have a higher risk of islet autoimmunity (IAA) and rapid progression to type 1 diabetes (T1D), a study has found.
Special Reports
Product Highlight - Bilaxten ODT
16 Mar 2022
Bilastine 10 mg orodispersible tablet
Kids hard-hit by Delta; which ART performs best?
Elvira Manzano, 24 Oct 2021
That COVID-19 mostly spared children might be changing. The Delta variant has taken a severe, unthinkable toll on kids – at least in Arkansas, US, reports an expert at IDWeek 2021.
ID NOW rapid molecular assay an effective COVID-19 test for kids
Roshini Claire Anthony, 20 Oct 2021

A large retrospective study from the US, presented at IDWeek 2021, has shown that the Abbott ID NOW rapid molecular COVID-19 assay is highly sensitive and specific at detecting SARS-CoV-2 infection in a paediatric population.

Combined Ag/Ab rapid testing boosts case-finding in COVID-19
Elvira Manzano, 29 Jul 2021
A rapid and affordable test for diagnosing COVID-19 outside the walls of the healthcare units could improve case-finding, contact tracing, and infection control, says an expert during a pre-ECCMID 2021 session.
Product Highlight - Zinforo
16 Jun 2021
Ceftaroline fosamil 600 mg powder for infusion
Navigating the CPP patient journey – case-based discussion for nurses
06 May 2021
In a webinar held on 27 March 2021, paediatric endocrinology nurses Karen Blair, Kate Davies, and Siti Zarina Yaakop shared insights and clinical experience based on their frontline roles in caring for patients with central precocious puberty (CPP) and supporting their family members.
A Guide on Primary Immunodeficiency Disease and Allergies
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Conference Reports
Timing of maternal antibiotic administration affects infant gut microbiome
Audrey Abella, 28 Jun 2021
Maternal administration of antibiotics prior to Caesarean section (CS) disrupts infant microbial colonization, according to the findings of the MAMI* trial presented at WCPGHAN 2021.
Bioactive nutrient-enriched infant formula may enhance neurocognitive outcomes
Elaine Soliven, 22 Jun 2021
A new infant formula supplemented with bioactive nutrients — containing MFGM* components, LC-PUFAs**, and synbiotics — may improve neurocognitive function and brain development in healthy children at 6 years of age, according to the COGNIS*** study presented at WCPGHAN 2021.
New anti-regurgitation formula confers benefit for infants with severe GI burden
Audrey Abella, 21 Jun 2021
A novel anti-regurgitation (AR) formula combining carob bean gum (CBG) with prebiotics and postbiotics was found to have a more pronounced benefit for infants with more severe gastrointestinal (GI) symptoms, according to the results of a post hoc analysis presented at WCPGHAN 2021.
Undiagnosed coeliac disease in children common, indicates need for widespread screening
Jairia Dela Cruz, 14 Jun 2021
Coeliac disease cases among school age children have doubled over two and a half decades, and without a wider screening strategy, most cases will remain undiagnosed, as shown in the CELI SCREEN trial.
Mothers passing on HBV to children due to patchy hospital policies across Europe
Stephen Padilla, 14 Jun 2021
A recent European survey has found major discrepancies and gaps in hospital policies and procedures to prevent the direct transmission of hepatitis B virus (HBV) from mother to child, particularly before and after birth.
Omega-3 supplements may up risk of AF
Elvira Manzano, 09 Jun 2021
Children whose mothers had taken fish oil supplements during the second half of pregnancy appeared to have better problem-solving skills and attention focus at age 10 vs those whose mothers had consumed folic acid alone or no supplements at all in a study presented at WCPGHAN 2021.
Dupilumab an alternative for children with severe AD
Audrey Abella, 19 May 2021
The addition of the monoclonal antibody dupilumab to a standard topical corticosteroid (TCS) regimen led to significant improvements in scoring AD (SCORAD*) and its components, as well as EASI** scores, in children with severe atopic dermatitis (AD), according to data from the phase III LIBERTY AD PEDS trial presented at PAS 2021.